Get the Stockscreener App
1.97
3.43%
-0.07
After Hours:
2.07
0.10
+5.08%
Heartbeam Inc Stock (BEAT) Latest News
HeartBeam Raises $11.5M: What This Capital Injection Means for Its Commercial Launch Timeline - StockTitan
Heartbeam director Richard Ferrari buys $50,000 in stock By Investing.com - Investing.com Australia
Heartbeam director Richard Ferrari buys $50,000 in stock - Investing.com India
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock By Investing.com - Investing.com Nigeria
Heartbeam CFO Tim Cruickshank buys $29,999 in company stock - Investing.com
HeartBeam announces pricing of UPO - Medical Buyer
HeartBeam submits 510(k) application to FDA for ECG software - MSN
HeartBeam sets price for $10 million stock offering - MSN
HeartBeam prices public offering of 5.88M shares; shares down - MSN
HeartBeam Secures Major Funding: FDA-Cleared Cardiac Innovation Gets $10M Boost - StockTitan
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock - Business Wire
US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software - The Globe and Mail
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Submits 12-Lead ECG Synthesis Software to FDA - MPO-mag
BEATHeartbeam, Inc. Latest Stock News & Market Updates - StockTitan
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software - Business Wire
Blaize Appoints Yoshiaki Fujimori and George de Urioste to Board of Directors - Business Wire
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices
FDA clearance adds glow to Heartbeam prospects - BioWorld Online
HeartBeam Wins FDA Nod for Home High-Fidelity Heart Monitor - MPO-mag
HeartBeam announces FDA clearance for high-fidelity ECG system - TipRanks
Heartbeam stock soars to 52-week high, hits $3.48 - Investing.com
FDA clears HeartBeam's novel ECG system for arrhythmia - Investing.com India
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology - Business Wire
HeartBeam And 2 Other US Penny Stocks With Promising Potential - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
HeartBeam rises on positive data from two studies on its vector-based technology - MSN
HeartBeam ECG technology shows promise in clinical studies By Investing.com - Investing.com Australia
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference - BioSpace
HeartBeam Touts Data from Study of Vector-Based Tech - MPO-mag
HeartBeam ECG technology shows promise in clinical studies - Investing.com India
HeartBeam announces positive data from two studies at AHA - TipRanks
HeartBeam's ECG Tech Shows 94% Sensitivity, 100% Specificity in Clinical Studies - StockTitan
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart
HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer
HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks
HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan
HeartBeam Reports Third Quarter 2024 Results - Business Wire
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
0.22%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):